RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Immorta Bio

Immorta Bio

Immortabio is a biotechnology company developing AI-enabled personalized therapeutics to treat diseases of aging.

Latest funding

Seed ·

Amount not disclosed in a source on record.

Funding history ↓
Website: immortabio.com.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biotechnology, Life Science, Product Research.
Stage: Seed.
Based in: Miami Beach, United States.
Last round: Oct 16, 2026 · 7 days ago.
Domain age: 3 years.
On Recent Funding since: Oct 20, 2026.
About Immorta Bio

Immorta Bio is a company based in Miami Beach, United States. Recent Funding lists it under Health and bio. Its latest known round is a Seed round (October 2026); no sourced amount is on record for it yet. Its team on record includes Boris Reznik (CEO), Armin Rath (Chief Business Officer), Thomas Ichim (President and Chief Scientific Officer) and 1 other.

Funding rounds

  1. Seed · amount undisclosed
    Source: sec.gov
  2. Website created

Team

Similar Health and bio companies

Questions and sources

Immorta Bio: questions and answers

Who works at Immorta Bio?
Team members on record: Boris Reznik (CEO), Armin Rath (Chief Business Officer), Thomas Ichim (President and Chief Scientific Officer) and Vlad Bykoriz (Chief Medical Officer).
Where is Immorta Bio based?
Immorta Bio is based in Miami Beach, United States.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/immorta-bio (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy